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Introduction
Postpartum hemorrhage (PPH) is the leading cause of 
maternal mortality in all over the world and a major cause 
of severe acute maternal morbidity even in well resourced 
settings [1, 2]. It is a leading reason for peripartum hysterec-
tomy, admission of pregnant women to intensive care units, 
and massive blood transfusion. In the most severe cases, 
hemorrhagic shock may lead to anterior pituitary ischemia, 
occult myocardial ischemia, dilutional coagulopathy [3, 5]. 
Post-partum anemia increases the risk of post-partum de-
pression [4].  The majority of these maternal complications 
can be avoided through the active management of the third 
stage of labor, correct diagnosis of postpartum hemorrhage 
and adequate treatment [5-8].
The uteroplacental circulation starts with the maternal 
blood flow into the intervillous space through decidual spi-
ral arteries (fig. 1).
During placental separation, these vessels are tied off the 
implantation site that induces bleeding from placental site. 
Reduction in uterine volume after the delivery of the neo-
nate is the result of: 
- Strong third-stage contractions
- Placental delivery
- Myometrial contraction
- Compression of spiral arteries
- Clotting and obliteration of the lumen of spiral arteries 
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Abstract
Background: Postpartum hemorrhage (PPH) is a major public health problem due to complications that have a direct impact 
on the most important reproductive health indicators: maternal morbidity and mortality.  It is a leading reason for peripartum 
hysterectomy, admission of pregnant women to intensive care units, and massive blood transfusion.  In the most severe cases, 
hemorrhagic shock may lead to anterior pituitary ischemia, occult myocardial ischemia, dilutional coagulopathy.  Post-partum 
anemia increases the risk of post-partum depression.  To decrease the incidence of postpartum hemorrhage the conditions that 
are known to be associated with PPH and these women should be identified. Careful anamnesis and obstetrical examination 
should be done to screen for risk factors in pregnancy and labor. To assure minimal blood loss during delivery several measures 
are proposed in international protocols. The knowledge of prophylaxis measures is useful to reduce maternal mortality and 
morbidity from PPH.
Conclusions: The knowledge of prophylaxis measures is useful to reduce maternal mortality and morbidity from PPH. Actually, 
for prophylaxis of postpartum hemorrhage, evidence based medicine recommend correction of anaemia, use of the partograph 
in labor and the close supervision first two hours after the delivery.
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in the superficial myometrium at the placental implantation 
site.
This is why fatal postpartum hemorrhage can result 
from uterine atony. Adhered placental pieces or large blood 
clots that prevent effective myometrial contraction will also 
stimulate bleeding. 
Definition. On average, women will lose about 500 
ml of blood in a vaginal delivery, 1000 ml in cesarien sec-
tion, and 1500 ml in a cesarean hysterectomy [9, 10, 11]. In 
2012 WHO defined Primary Postpartum Haemorrhage as a 
blood loss of 500 ml or more within 24 hours after birth. In 
other guidelines and protocols primary PPH is commonly 
defined as excessive blood loss of 500 ml or more within 24 
hours after the delivery of the baby (after the second stage of 
labor) in a vaginal delivery, and 1000 ml in a cesarean sec-
tion [9, 10, 14, 18]. 
Risk factors. Unfortunately, PPH is a complication that 
for many women cannot be predicted. There are, however, 
some conditions that are known to be associated with PPH 
and these women should be identified. Risk factors for PPH 
may present antenatally or intrapartum; carefull anamnesis 
and obstetrical examination should be done to screen for 
risk factors in pregnancy and labor [11, 12]. The following 
risk factors for PPH are: anemia diagnosed in the beginig of 
pregnancy, past history of severe PPH, anticoagulant drugs 
in pregnancy, severe pre-eclampsia, HELLP syndrome, ute-
REvIEw ARTIClES The Moldovan Medical Journal, December 2017, Vol. 60, No 4
rine fibromas, multiple pregnancy, fetal macrosomia, obe-
sity BMI>35, general anaesthesia, failure to progress in the 
second stage, prolonged third stage of labor, retained pla-
centa, placenta accreta, episiotomy, perineal laceration [13-
16]. Clinicians must be aware of risk factors for PPH and 
should take these into account when counselling women 
about place and modality of the delivery. Women with sig-
nificant risk factors for PPH should deliver in a unit with 
rapid access to blood and blood products. Women with 
known risk factors for PPH should only be delivered in a 
hospital with a blood bank on site [17, 18].
Prophylaxis.  In order to minimize the risk of PPH we 
have to reduce blood loss during delivery. 
To assure minimal blood loss during delivery several 
measures are proposed in international protocols:
1.  Correction of anaemia.
·	Screening for anaemia at the first antenatal visit and 
appropriate investigations should be offered to all 
pregnant women [19, 20]
·	The aim of antenatal care is to ensure a haemoglobin 
level at 110 gms/dl
·	 In order to prevent anemia iron and folate supplemen-
tation should be offered to all pregnant women
·	The most common cause of anaemia in pregnancy is 
iron deficiency [21, 22]
·	 Iron should be replaced orally or by iron infusion. Par-
enteral iron will be given if oral iron is not tolerated or 
not absorbed or the term is approaching and there is no 
time for oral supplementation to be effective [23-24]
·	 If hemoglobin level is less than 8gms/dl further in-
vestigation should be done to diagnose the cause of 
anemia [25]. Hemoglobin level should be checked in 
all women at the onset of labor. If less than 10gms/dl, 
they should be referred to continue labor in the refer-
ral hospital where blood is available on site [26, 27].
2. Identification of patients who refuse blood transfu-
sion. Some women refuse the use of blood products for 
religious pregnant women may refuse blood transfusion 
because of their religious believes or infection reason. Preg-
nant women who refuse blood transfusion are at increased 
risk of severe morbidity, maternal death and perinatal com-
plicatins [28, 29, 30]. In these patients all the steps should be 
done to minimize the risk of PPH. Antenatal care and de-
livery in a level 2 or 3 hospital under specialist supervision 
and specialist consultation at haematology department [31]:
·	Optimization of iron stores with haematics
·	Delivery in the facility with availability of Haemopure 
(a blood analogue)
·	Delivery in the facility with availability of auto trans-
fusion (cell salvage technique) 
Fig. 1.  Schematic presentation of the endometrial 
vascular system. The primate endometrium is composed 
of the stratum basalis and stratum functionalis.  
Uterine arteries branch within the myometrium to yield 
the arcuate and radial arteries.
Fig. 2.  Anterior placenta in the third trimester of pregnancy: hyperechoic placenta is surrounded  
by the hypoechoic myometrium, some calsifications and vascular lacks are seen.
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·	Early use of uterotonic agents, oxytocin 5 iu by slow 
intravenous injection for prophylaxis in the context 
of caesarean delivery and for women delivering vagi-
nally, oxytocin 10 iu by intramuscular injection is the 
regimen of choice for prophylaxis in the third stage of 
labour. Intramuscular oxytocin should be adminis-
tered with the birth of the anterior shoulder, or imme-
diately after the birth of the baby and before the cord 
is clamped and cut.
·	Early application of surgical procedures to stop the 
hemorrhage [32-36].
3. Determination of placental localization via ultrasound 
(fig. 2).
·	Recognition, preparation and management of women 
with placenta praevia decrease the risk of catastrophic 
haemorrhage.
·	Patients with suspected morbidly adherent placenta-
tion should be detected before delivery in order to 
organize the delivery in the specialized units [37, 38].
4. Use of oxytocin and prostoglandins. Induction of la-
bor should be done with precautions and with strict indi-
cations because using excessive dose of prostaglandins and 
oxytocin can lead to uterine rupture. Induction with pros-
taglandins in the presence of uterine activity can provoke 
uterine. Inappropriate use of oxytocin if feto-pelvic dispro-
portion or malpresentation are suspected can lead to uter-
ine rupture [39, 40, 41].
5. No to the “Active management of the third stage of 
labour”. The administration of a prophylactic uterotonic af-
ter the delivery of a baby and the controlled cord traction 
are recommended.The agent of choice for prophylaxis in 
the third stage of labour is oxytocin10 iu by intramuscu-
lar injection [42, 43, 44].  In comparison with the active 
management, the expectant management involves waiting 
for signs of placenta separation and spontaneous delivery. 
Compared with expectant management, the active man-
agement of the third stage of labour is associated with a 
substantial reduction of PPH [45,46]. Active management 
of the third stage includes routine early clamping of the 
umbilical cord. A systematic review showed that delaying 
clamping for at least 2 minutes is beneficial to the newborn 
and that the benefits extend into infancy [47, 48]. That is 
why active management of the third stage of labour can no 
longer be recommended [49].
6. Routine episiotomy. Episiotomy means incision of 
the perineum in order to enlarge the vaginal orifice during 
the second stage of labor. It can laterally be done midline or 
medio-lateral. There are routine episiotomy that is done for 
every birth and restrictive episiotomy- only under indica-
tions. Restrictive episiotomy results in less severe perineal 
trauma. Restrictive episiotomy results in less posterior peri-
neal trauma, less suturing and fewer PPH rates [50, 51, 52].
7. Use of partogram in labour. The partograph is a 
graphic record of the progress of labour and relevant details 
of the mother and fetus. Use of partogram helps to assure 
appropriate care and monitoring of women in labour be-
cause it is an early warning system to detect labour that was 
not progressing normally [53, 54]. The partograph has been 
shown to be effective in:
·	Prevention of prolonged labor with the associated 
PPH due to the uterine atony, 
·	Prevention of prolonged labor with the associated 
PPH due to the chorioamniotis,
·	Prevention of prolonged obstructed labor- the uterine 
rupture and associated catastrophic haemorrhage,
·	Prevention of scar dehiscence and uterine rupture in 
case of women having labour after one caesarean sec-
tion [54, 55, 56].
8. Close monitoring during first 2 hours after birth.  Fol-
lowing delivery all women will be observed in the delivery 
room for 2 hours. The observation include her general phys-
ical condition, as shown by her colour, respiration and her 
own report of how she feels, the vaginal blood loss, blood 
pressure, heart rate. Early detection of PPH before blood 
loss has become severe and will result in earlier initiation 
of resuscitation and definitive treatment to arrest haemor-
rhage, thus reducing the morbidity from the PPH [58, 59, 
60].
Diagnosis.  The diagnosis of PPH is established by ob-
serving the amount of bleeding and the patient’s clinical sta-
tus. Physiological increase in circulating blood volume dur-
ing pregnancy means that the signs of hypovolemic shock 
become less sensitive [61, 62].
Tachycardia, tachypnoea and a slight recordable fall in 
systolic blood pressure occur with blood loss of 1000–1500 
ml. A systolic blood pressure below 80 mmHg, associated 
with worsening tachycardia, tachypnoea and altered men-
tal state, usually indicates a PPH in excess of 1500 ml [63, 
64, 65].
Blood loss estimation.  We have taken into consider-
ation that estimation of blood loss is notoriously inaccu-
rate, especially with excessive bleeding. Also, physiological 
changes of pregnancy may mask the severity of blood loss. 
Clinical signs and symptoms should be included in the as-
sessment of PPH. Estimation of blood loss should begin im-
mediately after the infant’s birth and prior to delivery of the 
placenta. Urinary catheter should be placed as soon as pos-
sible. All blood-soaked materials and clots should be taken 
into consideration to determine cumulative volume. 1 gram 
weight = 1milliliter blood loss volume [67, 69, 70].
Methods of measuring blood loss were divided into five 
categories: 
	Visual estimation,
	Direct measurement,
	Gravimetric,
	Photometry,
	Miscellaneous methods. 
For this purpose a basin in front of the external genita-
lia, a douche pan, underbuttocks drapes with a graduated 
pouch for measurement, weigh sponges and suction con-
tents placed on a scale can be used.
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Clinical signs of hemorrhage are: cool extremities, de-
creased urine output, dizziness, marked pallor, hypoten-
sion with sitting, anxious state, oliguria / anuria, agitation, 
confusion, loss of consciousness, unstable blood pressure 
[71,72,73].
Causes of PPH: The modern approach to the postpar-
tum haemorrhage implies the 4T approach (tab. 1) that 
means implications of 4 factors in the realisation of haemo-
stasis [74, 75, 76].
These 4 T of obstetric hemorrrhage are:
1. Tone (Uterine atony).
2. Trauma (Genital trauma including damage to vulva, 
vagina, cervix and uterus). 
3. Tissue (Retained and invasive placenta).
4. Thrombin (Coagulopathy).
Table 1
“4 T” causes of post-partum hemorrhage
Tissue. Placental causes:
Retained placenta
Retained clots
Placenta previa
Placenta accreta/increta/
percreta
Hydatiform mole
Tone. Uterine atony.
Hyperstimulation
High parity 
Obstructed labor 
Early preterm labor
Uterine overdistention
Large fetus- estimated fetal weight 
> 4kg
Multiple fetuses 
Hydramnios 
Labor induction 
Anesthesia or analgesia
Halogenated agents 
Conduction analgesia with hypo-
tension 
Labor abnormalities
Rapid labor 
Prolonged labor 
Augmented labor 
Previous uterine atony
Chorioamnionitis
Sepsis syndrome
Trauma. Injuries to the birth 
canal
Episiotomy and lacerations 
Forceps or vacuum delivery 
Cesarean delivery or hyste-
rectomy
Uterine rupture
Previously scarred uterus 
Intrauterine manipulation 
Midforceps rotation 
Breech extraction
Shoulder dystocia
Thrombin. Coagulopathy
Congenital coagulopathies 
Placental abruption
Sepsis syndrome 
Severe preeclampsia
Syndrome
Acute fatty liver 
Anticoagulant treatment 
Amnionic-fluid embolism 
Prolonged retention of dead fetus
Massive transfusions
If the placenta is out, the most common cause is uterine 
atony, diagnosed by palpation of a poorly contracted uterus. 
This is first done by knowing if the placenta has been deliv-
ered or not. If retained then the management follows along 
the retained placenta route in the algorithm. Perineal tears 
will be diagnosed on routine inspection after vaginal deliv-
ery. If there is no response to oxytocin infusion additional 
oxytocic agents should be given as indicated in the algo-
rithm. First line is represented by ergometrine and miso-
prostol, but intramyometrial PGF2alpha requires a special 
indications to administer. However at this stage, in the pres-
ence of persisting bleeding, it is very important to exclude 
another cause such as deep vaginal lacerations, cervical 
tears and/or retained fragments of placenta or membranes.
Conclusions
The knowledge of prophylaxis measures is useful to re-
duce maternal mortality and morbidity from PPH. Actually, 
for prophylaxis of postpartum hemorrhage, evidence based 
medicine recommend correction of anaemia, use of of the 
partograph in labor and the close supervision first two 
hours after the delivery.
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